Denoy, Reynaldo T.
HRN: 27-05-62 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/01/2025
CEFTAZIDIME 1GM (VIAL)
05/01/2025
05/08/2025
IV
1g
Q8hrs
CAP-MR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes